Can Reducing Inflammation Alleviate Fatigue in Early-Stage Breast Cancer Patients?

Recent research highlights the potential link between inflammation and fatigue experienced by women with early-stage breast cancer. Published in the journal Cancer, this study explores how inflammatory responses may contribute to various aspects of cancer-related fatigue, a persistent condition that causes physical, emotional, and cognitive exhaustion.

Cancer-related fatigue is a distressing symptom often driven by the activation of inflammatory processes, either by the tumor itself or as a consequence of treatments like radiation and chemotherapy. Despite its prevalence, the specific role of inflammation across the cancer journey has not been fully understood.

To investigate this, scientists from the University of California, Los Angeles (UCLA) conducted a comprehensive analysis involving 192 women with early-stage breast cancer. They measured markers of inflammation in the blood, focusing on cytokines such as TNF-α and IL-6, along with downstream markers like sTNF-RII and C-reactive protein (CRP). The participants' fatigue levels were assessed at multiple points: before treatment, during, and in the 18 months following therapy.

Findings revealed that higher levels of inflammatory markers such as TNF-α, sTNF-RII, and IL-6 were significantly associated with increased general fatigue, which includes feelings of tiredness and exhaustion. These relationships persisted even after accounting for factors like age, race, body mass index, and cancer stage. Specifically, increased inflammation was also linked to physical fatigue, characterized by feelings of weakness and heaviness. Interestingly, elevated levels of TNF-α and sTNF-RII were connected to lower emotional fatigue, suggesting a complex relationship between inflammation and different fatigue dimensions. However, no significant connection was found between inflammation and mental or cognitive fatigue.

The study's lead author, Dr. Julienne E. Bower, emphasized the implications of these findings, stating that inflammation appears to play a role in specific aspects of cancer-related fatigue and that these effects can persist long after treatment concludes. Understanding the biological underpinnings of fatigue could pave the way for targeted therapies aimed at reducing inflammation, ultimately improving the quality of life for breast cancer survivors.

This research underscores the importance of addressing inflammation as a potential therapeutic target for managing fatigue and highlights the need for further studies to develop effective interventions.

Source: https://medicalxpress.com/news/2025-10-inflammation-combat-fatigue-people-early.html